Unilife Corp  

(Public, NASDAQ:UNIS)   Watch this stock  
Find more results for UNIS
-0.047 (-5.84%)
Real-time:   2:23PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.75 - 0.85
52 week 0.70 - 4.90
Open 0.85
Vol / Avg. 437,023.00/786,878.00
Mkt cap 112.69M
P/E     -
Div/yield     -
EPS -0.80
Shares 139.25M
Beta 0.78
Inst. own 34%
Feb 8, 2016
Unilife Corp Extraordinary Shareholders Meeting - 4:00PM EST - Add to calendar
Feb 8, 2016
Q2 2016 Unilife Corp Earnings Release (Estimated) Add to calendar
Nov 16, 2015
Unilife Corp Annual Shareholders Meeting
Nov 13, 2015
Unilife Corp Annual Shareholders Meeting (Estimated)
Nov 9, 2015
Q1 2016 Unilife Corp Earnings Call - Webcast
Nov 9, 2015
Q1 2016 Unilife Corp Earnings Release
Sep 14, 2015
Q4 2015 Unilife Corp Earnings Call - Webcast
Sep 14, 2015
Q4 2015 Unilife Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2015
Net profit margin -811.55% -690.45%
Operating margin -740.13% -611.25%
EBITD margin - -573.83%
Return on average assets -106.98% -103.30%
Return on average equity - -
Employees 230 -
CDP Score - -


250 Cross Farm Lane
YORK, PA 17406
United States - Map
+1-717-3843400 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Unilife Corporation is a medical device manufacturer and component supplier. The Company is engaged in the designing, development and manufacturing of injectable drug delivery systems. It has a portfolio of product platforms, including pre-filled syringes, wearable injectors, insulin delivery systems, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems and other systems. The Company's Pre-filled Syringes include Unifill platform that includes Unifill, Unifill Finesse, Unifill Select, Unifill Nexus and Unifill Allure. The Company offers ReadyToGo portfolio of wearable injectors. Its Imperium platform is designed to be prefilled with insulin and is supplied ready for multi-day wear. Its product configurations available within the EZMix platform include AutoMix Presto, EZMix Genesis, EZMix Engage and EZMix Prodigy. The Company's Ocular delivery systems include Ocu-ject, Ocu-mix and Depot-ject.

Officers and directors

Alan D. Shortall Chairman of the Board, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Ramin Mojdehbakhsh Ph.D. President, Chief Operating Officer
Age: 54
Bio & Compensation  - Reuters
David C. Hastings Chief Financial Officer, Senior Vice President
Age: 54
Bio & Compensation  - Reuters
Dennis P. Pyers Senior Vice President, Chief Accounting Officer, Controller, Treasurer
Age: 54
Bio & Compensation  - Reuters
John Ryan J.D. Senior Vice President, General Counsel, Secretary
Age: 45
Bio & Compensation  - Reuters
Kevin Sellers Senior Vice President - Marketing and Communications
Bio & Compensation  - Reuters
Richard L. Beckman M.D. Senior Vice President and Chief Medical Officer
Bio & Compensation  - Reuters
Mark V. Iampietro Chief Compliance Officer, Vice President of Corporate Quality and Regulatory Affairs
Age: 62
Bio & Compensation  - Reuters
Mary Katherine Wold Non-Executive Vice Chairman of the Board, Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
Jeff Carter Non-Executive Director
Age: 57
Bio & Compensation  - Reuters